|
1
|
Friedenstein AJ, Chailakhyan RK and
Gerasimov UV: Bone marrow osteogenic stem cells: In vitro
cultivation and transplantation in diffusion chambers. Cell Tissue
Kinet. 20:263–272. 1987.PubMed/NCBI
|
|
2
|
Bruder SP, Jaiswal N and Haynesworth SE:
Growth kinetics, self-renewal, and the osteogenic potential of
purified human mesenchymal stem cells during extensive
subcultivation and following cryopreservation. J Cell Biochem.
64:278–294. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang Y, Jahagirdar BN, Reinhardt RL,
Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund
T, Blackstad M, et al: Pluripotency of mesenchymal stem cells
derived from adult marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bianco P, Robey PG and Simmons PJ:
Mesenchymal stem cells: Revisiting history, concepts, and assays.
Cell Stem Cell. 2:313–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moore KA and Elmendorf SC: Propagule vs.
niche limitation: Untangling the mechanisms behind plant species'
distributions. Ecol Lett. 9:797–804. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Timmermans F, Plum J, Yöder MC, Ingram DA,
Vandekerckhove B and Case J: Endothelial progenitor cells: Identity
defined? J Cell Mol Med. 13:87–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Werner N, Junk S, Laufs U, Link A, Walenta
K, Bohm M and Nickenig G: Intravenous transfusion of endothelial
progenitor cells reduces neointima formation following vascular
injury. Circ Res. 93:e17–e24. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Atluri P, Miller JS, Emery RJ, Hung G,
Trubelja A, Cohen JE, Lloyd K, Han J, Gaffey AC, MacArthur JW, et
al: Tissue engineered, hydrogel-based endothelial progenitor cell
therapy robustly revascularizes ischemic myocardium and preserves
ventricular function. J Thorac Cardiovasc Surg. 148:1090–1098.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang H, Xian L, Lin Z, Yang C, Zhang M,
Feng W, Peng X, Chen X and Wu X: Endothelial progenitor cells as a
possible component of stem cell niche to promote self-renewal of
mesenchymal stem cells. Mol Cell Biochem. 397:235–243. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao X, Wu X, Frassica D, Yu B, Pang L,
Xian L, Wan M, Lei W, Armour M, Tryggestad E, et al: Irradiation
induces bone injury by damaging bone marrow microenvironment for
stem cells. Proc Natl Acad Sci. 108:1609–1614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kinnaird T, Stabile E, Burnett MS, Lee CW,
Barr S, Fuchs S and Epstein SE: Marrow-derived stromal cells
express genes encoding a broad spectrum of arteriogenic cytokines
and promote in vitro and in vivo arteriogenesis through paracrine
mechanisms. Circ Res. 94:678–685. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nagaya N, Kangawa K, Itoh T, Iwase T,
Murakami S, Miyahara Y, Fujii T, Uematsu M, Ohgushi H, Yamagishi M,
et al: Transplantation of mesenchymal stem cells improves cardiac
function in a rat model of dilated cardiomyopathy. Circulation.
112:1128–1135. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Noguchi S: The biological function of
insulin-like growth factor-I in myogenesis and its therapeutic
effect on muscular dystrophy. Acta Myol. 24:115–118.
2005.PubMed/NCBI
|
|
14
|
hen Z, Seyfert HM, Löhrke B, Schneider F,
Zitnan R, Chudy A, Kuhla S, Hammon HM, Blum JW, Martens H, et al:
An energy-rich diet causes rumen papillae proliferation associated
with more IGF type 1 receptors and increased plasma IGF-1
concentrations in young goats. J Nutr. 134:11–17. 2004.PubMed/NCBI
|
|
15
|
Sandri M, Barberi L, Bijlsma AY, Blaauw B,
Dyar KA, Milan G, Mammucari C, Meskers CG, Pallafacchina G, Paoli
A, et al: Signalling pathways regulating muscle mass in ageing
skeletal muscle: The role of the IGF1-Akt-mTOR-FoxO pathway.
Biogerontology. 14:303–323. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu M and Zhang S: Amphioxus IGF-like
peptide induces mouse muscle cell development via binding to IGF
receptors and activating MAPK and PI3K/Akt signalling pathways. Mol
Cell Endocrinol. 343:45–54. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu X, Pang L, Lei W, Lu W, Li J, Li Z,
Frassica FJ, Chen X, Wan M and Cao X: Inhibition of Sca-1-positve
skeletal stem cell recruitment by alendronate blunts the anabolic
effects of parathyroid hormone on bone remodeling. Cell Stem Cell.
7:571–580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li W, Yang SY, Hu ZF, Winslet MC, Wang W
and Seifalian AM: Growth factors enhance endothelial progenitor
cell proliferation under high-glucose conditions. Med Sci Monit.
15:BR357–BR363. 2009.PubMed/NCBI
|
|
20
|
Shavlakadze T, Chai J, Maley K, Cozens G,
Grounds G, Winn N, Rosenthal N and Grounds MD: A growth stimulus is
needed for IGF-1 to induce skeletal muscle hypertrophy in vivo. J
Cell Sci. 123:960–971. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bibollet-Bahena O and Almazan G:
IGF-1-stimulated protein synthesis in oligodendrocyte progenitors
requires PI3K/mTOR/Akt and MEK/ERK Pathways. J Neurochem.
109:1440–1451. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blum JW and Baumrucker CR: Colostral and
milk insulin-like growth factors and related substances: Mammary
gland and neonatal (intestinal and systemic) targets. Domest Anim
Endocrinol. 23:101–110. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Zhu X, Li X, Wang W, Wang X, Liu
L, Deng Q, Bai G, Wang J, Feng H, et al: Effects of copper on
proliferation and autocrine secretion of insulin-like growth
factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in
chondrocytes from newborn pigs in vitro. Biol Trace Elem Res.
144:588–596. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu Y, Mu J, Fan Z, Lei G, Yan M, Wang S,
Tang C, Wang Z, Yu J and Zhang G: Insulin-like growth factor 1
enhances the proliferation and osteogenic differentiation of human
periodontal ligament stem cells via ERK and JNK MAPK pathways.
Histochem Cell Biol. 137:513–525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thum T, Hoeber S, Froese S, Klink I,
Stichtenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD,
Poole-Wilson PA, et al: Age-dependent impairment of endothelial
progenitor cells is corrected by growth hormone mediated increase
of insulin-like growth factor-1. Circ Res. 100:434–443. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Glass DJ: Skeletal muscle hypertrophy and
atrophy signalling pathways. Int J Biochem Cell Biol. 37:1974–1978.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fedorovich NE, Haverslag RT, Dhert WJ and
Alblas J: The role of endothelial progenitor cells in
prevascularized bone tissue engineering: Development of
heterogeneous constructs. Tissue Eng Part A. 16:2355–2367. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chakravarthy MV, Abraha TW, Schwartz RJ,
Fiorotto ML and Booth FW: Insulin-like growth factor-I extends in
vitro replicative life span of skeletal muscle satellite cells by
enhancing G1/S cell cycle progression via the activation of
phosphatidylinositol 3′-kinase/Akt signaling pathway. J Biol Chem.
275:35942–35952. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Glass DJ: PI3 kinase regulation of
skeletal muscle hypertrophy and atrophy. Curr Top Microbiol
Immunol. 346:267–278. 2010.PubMed/NCBI
|
